EXPERIMENTAL DIABETES IN THE RAT CAUSES AN INSULIN-REVERSIBLE DECREASE IN RENAL 25-HYDROXYVITAMIN-D3-1ALPHA-HYDROXYLASE ACTIVITY
EXPERIMENTAL DIABETES IN THE RAT CAUSES AN INSULIN-REVERSIBLE DECREASE IN RENAL 25-HYDROXYVITAMIN-D3-1ALPHA-HYDROXYLASE ACTIVITY
复制标题
DOI:
10.1210/endo-107-1-300
复制
发表时间:
1980-01-01
期刊:
影响因子:
4.8
通讯作者:
TOBIASSEN, O
中科院分区:
文献类型:
--
作者:
MARTIN, E;KHALIL, SM;TOBIASSEN, O
The decreased intestinal mucosal absorption of Ca observed in the diabetic rat was attributed to low circulating 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] levels. The cause of the depressed plasma 1,25-(OH)2D3 and the possibility that in diabetes the incorporation of 1,25-(OH)2D3 into intestinal mucosa may be defective were investigated. In diabetic rats, the metabolic clearance of i.v. [3H]1,25-(OH)2D3 was not increased, suggesting that their low plasma 1,25-(OH)2D3 levels were due to decreased formation. The in vivo conversion of a standard dose of [3H]25-hydroxyvitamin D3 ([3H]25-OHD3) to [3H]1,25-(OH)2D3 was reduced by 60% in diabetic rats; it returned to normal by insulin treatment. Serum Ca and P levels were unaffected by diabetes. Since diabetes did not augment 1,25-(OH)2D3 catabolism, the decreased conversion of [3H]25OHD3 to [3H]1,25-(OH)2D3 indicates that the activity of the renal 25-OH-D3-1.alpha.-hydroxylase is decreased in diabetic rats. Intestinal mucosa of diabetic rats was significantly hypertrophied. There was no intrinsic defect in the incorporation of [3H]1,25-(OH)2D3 The depressed intestinal Ca absorption in diabetic rats apparently is due to decreased delivery of 1,25-(OH)2D3 to the intestinal mucosa consequent to decreased renal 1.alpha.-hydroxylase activity. Whether the decrease in 1.alpha.-hydroxylase activity is due to insulin deficiency or is a secondary consequence of the diabetic state is unknown.